ecancer

Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany

6 Jan 2015

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden

6 Jan 2015

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France

6 Jan 2015

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden

6 Jan 2015

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium

6 Jan 2015

Effects of aspirin on cancer outcomes

Prof Peter Rothwell - University of Oxford, Oxford, UK

19 Dec 2014

CLL at ASH 2014: Expert discussion

Prof John Gribben and Prof Stephan Stilgenbauer

12 Dec 2014

Examining cell-free DNA provides non-invasive detection of malignancies in Hodgkin lymphoma

Dr Peter Vandenberghe - Universitair Ziekenhuis Leuven, Leuven, Belgium

12 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele

8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger

8 Dec 2014

Busulfan exposure dose tested for MDS and AML

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA

8 Dec 2014

Oprozomib shows potential in the treatment of multiple myeloma

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA

8 Dec 2014

More from ecancer